---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-204332"
form_type: "8-K"
ticker: "TXMD"
cik: "0000025743"
company_name: "TherapeuticsMD, Inc."
filed_at: "2022-07-28T23:59:59+00:00"
generated_at: "2026-06-24T07:43:18.309215+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# TherapeuticsMD extends loan maturity by one day, evaluating Chapter 11 filing

## Summary
- Extended maturity of Financing Agreement from July 27 to July 28, 2022.
- Evaluating strategic alternatives including potential refinancing or Chapter 11 protection.
- Intends to maintain normal operations during evaluation.

## SEC filing metadata
- accession: 0001193125-22-204332
- form_type: 8-K
- ticker: TXMD
- cik: 0000025743
- company_name: TherapeuticsMD, Inc.
- filed_at: 2022-07-28T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/25743/000119312522204332/0001193125-22-204332-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/25743/000119312522204332/d379754d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-204332
- JSON: https://secwatch.observer/filing/0001193125-22-204332.json
- Plain text: https://secwatch.observer/filing/0001193125-22-204332.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.